(Total Views: 441)
Posted On: 09/26/2024 2:08:06 PM
Post# of 154147
I think this may have been the mouse study Dr. J was referring to when he mentioned going after the current mouse study we are in for Alzheimer's.
https://pubmed.ncbi.nlm.nih.gov/38215963/ CCR5 regulates Aβ1-42-induced learning and memory deficits in mice. I assume that the mice must first develop memory disfunction before they get Leronlimab, or are we going to inject Leronlimab at the beginning of the study to see if it prevents Alzheimer's? I hope it is a study to try to reverse it, but I don't recall the overall goal.
https://pubmed.ncbi.nlm.nih.gov/38215963/ CCR5 regulates Aβ1-42-induced learning and memory deficits in mice. I assume that the mice must first develop memory disfunction before they get Leronlimab, or are we going to inject Leronlimab at the beginning of the study to see if it prevents Alzheimer's? I hope it is a study to try to reverse it, but I don't recall the overall goal.
(2)
(0)
